BioCentury
ARTICLE | Company News

Serono licenses AZN's anastrozole for infertility

July 23, 2002 7:00 AM UTC

AstraZeneca (AZN; LSE:AZN) granted Serono (SRA; SWX:SEO) exclusive worldwide rights to develop and market anastrozole for ovulation induction and improvement of follicular development as a first-line ...